VALSARTAN 320 MG TABLET
For 30 tablets
Pharmacies pay
$4.90 filed
30 × $0.16341 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$10.12 filed
30 × $0.33722 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.1× estimated
Medicare paid 2.1× what pharmacies pay.
Part D averages every strength and form sold under “Valsartan” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$10.64 estimated
$4.90 + $0.74 (15%) + $5.00 fee per fill = $10.64
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
VALSARTAN 320 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as valsartan.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 12 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Camber Pharmaceuticals, Inc. and Macleods Pharmaceuticals Limited.
FDA’s Established Pharmacologic Class for it is Angiotensin 2 Receptor Blocker.
The NADAC file of 2026-10-14 prices it under 14 NDCs (National Drug Codes); the FDA directory lists 13 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $4.90 for 30 tablets (30 × $0.16341 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 12 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Alembic Pharmaceuticals Inc. | 2 | $0.16341 per EA filed |
| Amneal Pharmaceuticals LLC | 1 | $0.16341 per EA filed |
| Ascend Laboratories, LLC | 1 | $0.16341 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.16341 per EA filed |
| AvPAK | 1 | $0.16341 per EA filed |
| Camber Pharmaceuticals, Inc. | 1 | $0.16341 per EA filed |
| Dr. Reddy's Laboratories Limited | 1 | $0.16341 per EA filed |
| Macleods Pharmaceuticals Limited | 1 | $0.16341 per EA filed |
| Mylan Pharmaceuticals Inc. | 1 | $0.16341 per EA filed |
| Ohm Laboratories Inc. | 1 | $0.16341 per EA filed |
| Solco Healthcare US, LLC | 1 | $0.16341 per EA filed |
| Viona Pharmaceuticals Inc | 1 | $0.16341 per EA filed |
| Not listed as a package in the FDA directory | 1 | $0.16341 per EA filed |
All 14 NDCs, with labeler and price
- 00378-5815-77 · Mylan Pharmaceuticals Inc. · $0.16341 per EA · eff. 2026-09-23 filed
- 31722-0154-90 · Camber Pharmaceuticals, Inc. · $0.16341 per EA · eff. 2026-09-23 filed
- 33342-0065-10 · Macleods Pharmaceuticals Limited · $0.16341 per EA · eff. 2026-09-23 filed
- 43547-0370-09 · Solco Healthcare US, LLC · $0.16341 per EA · eff. 2026-09-23 filed
- 50268-0749-11 · not listed as a package in the FDA directory · $0.16341 per EA · eff. 2026-09-23 filed
- 50268-0749-13 · AvPAK · $0.16341 per EA · eff. 2026-09-23 filed
- 51660-0143-90 · Ohm Laboratories Inc. · $0.16341 per EA · eff. 2026-09-23 filed
- 55111-0734-90 · Dr. Reddy's Laboratories Limited · $0.16341 per EA · eff. 2026-09-23 filed
- 62332-0047-71 · Alembic Pharmaceuticals Inc. · $0.16341 per EA · eff. 2026-09-23 filed
- 62332-0047-90 · Alembic Pharmaceuticals Inc. · $0.16341 per EA · eff. 2026-09-23 filed
- 65162-0840-09 · Amneal Pharmaceuticals LLC · $0.16341 per EA · eff. 2026-09-23 filed
- 65862-0573-90 · Aurobindo Pharma Limited · $0.16341 per EA · eff. 2026-09-23 filed
- 67877-0418-90 · Ascend Laboratories, LLC · $0.16341 per EA · eff. 2026-09-23 filed
- 72578-0134-16 · Viona Pharmaceuticals Inc · $0.16341 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
7 other products in the NADAC file share the FDA nonproprietary name valsartan with VALSARTAN 320 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| DIOVAN 40 MG TABLET | $7.81625 per EA filed | $9.7221 per EA filed |
| DIOVAN 80 MG TABLET | $9.32714 per EA filed | $9.7221 per EA filed |
| DIOVAN 160 MG TABLET | $10.03773 per EA filed | $9.7221 per EA filed |
| DIOVAN 320 MG TABLET | $12.67445 per EA filed | $9.7221 per EA filed |
| VALSARTAN 40 MG TABLET | $0.0963 per EA filed | $0.33722 per EA filed |
| VALSARTAN 80 MG TABLET | $0.08197 per EA filed | $0.33722 per EA filed |
| VALSARTAN 160 MG TABLET | $0.10604 per EA filed | $0.33722 per EA filed |
| VALSARTAN 320 MG TABLET this page | $0.16341 per EA filed | $0.33722 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 14 NDCs’ NADAC prices is $0.16341 per EA filed.
Of the 107 other products in FDA’s Angiotensin 2 Receptor Blocker class priced per EA, 85 have a higher middle NADAC price and 22 a lower one. The one in the middle is OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5, at $1.15137 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $10.12 for 30 tablets, at an average of $0.33722 per EA in 2024 (2024-01-01 to 2024-12-31) for “Valsartan”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 4,691,604 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for VALSARTAN 320 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Valsartan / Valsartan: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- LOSARTAN POTASSIUM 100 MG TAB
- LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB
- ENTRESTO 24 MG-26 MG TABLET
- OLMESARTAN MEDOXOMIL 20 MG TAB
- IRBESARTAN 150 MG TABLET